by Rod Raynovich | Jun 30, 2011 | BIOgraph
The 2011 Bio Meeting was well attended surpassing last year’s number around 15,000. International participation continues to grow with 37% of attendees outside of the U.S. Virtually every country that has industry and universities is looking at biotech...
by Rod Raynovich | Jun 26, 2011 | 2023-24 Life Science Portfolios, BIOgraph
We will be attending the BIO Meeting in Washington DC and will not be posting as usual. Note that there were two news items over the weekend on our portfolio stocks: A positive article on Gilead (GILD) in Barron’s. Gilead Sciences Shares Could Rally –...
by Rod Raynovich | Jun 23, 2011 | BIOgraph, Macro
Techs and Biotechs Turn Around Its up- its down- its way down -its coming back.At the end of the day NASDAQ recovered up 0.66% after being down more than 1.4%, the Dow was down 0.49% and the S&P down o.28%. Crosscurrents were too numerous to cover: plunge in oil...
by Rod Raynovich | Jun 22, 2011 | BIOgraph
Last December we reviewed three low market cap diagnostic stocks that had product revenue, deal or news potential and value. All are up from our last review and Immucell(ICCC $6.97) has appreciated 100% and still has a market cap of only $20M.Immucell is focused in...
by Rod Raynovich | Jun 21, 2011 | 2023-24 Life Science Portfolios, BIOgraph
The market touched the March lows last Friday , down for the year, and buyers swarmed in.Biotechs were strong yesterday buffering tech weakness and today the baton was passed to several sectors with a broad rally especially with NASDAQ up 2.23%. The NASDAQ-100 qqq...
by Rod Raynovich | Jun 20, 2011 | 2023-24 Life Science Portfolios, BIOgraph
NASDAQ stocks rallied today just off March 2011 QQQ bottoms led by large cap biotech stocks.The NASDAQ 100 is up 0.6% led by Biogen Idec(BIIB) up 4.26%, Celgene (CELG) up 3.27%, and Gilead (GILD) up 1.5%.The rally would be stronger were it not for weak tech stocks...
by Rod Raynovich | Jun 17, 2011 | 2023-24 Life Science Portfolios, BIOgraph
Busy Day Today -Overall a Lot of Green Screen The diagnostics and tools sector has seen resilience over the past 30 days as the market corrected 7% or more.Bellwether large cap tools stocks with revenue growth such as ILMN,NEOG, TMO have held up well helped by M&A...
by Rod Raynovich | Jun 15, 2011 | BIOgraph, Macro
Europe debt woes, riots in Greece and a 3% CPI increase for a 12 month period spooked investors. All sectors sold off today with major indices down: NASDAQ off 1.77%,Dow off 1.5%,S&P off 1.7%. Energy, materials, technology and financials were weakest, and all down...
by Rod Raynovich | Jun 14, 2011 | BIOgraph
The market rallied today with the NASDAQ up 1.48 % and the S&P up 1.26%. The leading sectors today were capital goods , materials and energy. Biotechs overall were up only 0.8% but were much better even though our mid-cap index was up only 0.49%. Within the Rayno...
by Rod Raynovich | Jun 13, 2011 | BIOgraph
Following up on the previous post we can review selected small and mid-stocks participating in the ASCO Conference look at performance over 3 months from March 14 to June 13 including a 7% correction in the market overall. Most biotech stocks peaked in Q2 2011. See...
